Back to Results
First PageMeta Content
Pharmaceutical industry / Pharmaceuticals policy / Pharmacy / Food safety / Good manufacturing practice / National Institute for Health and Clinical Excellence / Zinc / Pharmaceutical sciences / Chemistry / Pharmacology


Invitation to manufacturers of Zinc-Sulfate to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification of Medicines Programme (November[removed]To support national and global efforts to in
Add to Reading List

Document Date: 2011-02-07 04:46:32

Open Document

File Size: 40,36 KB

Share Result on Facebook

City

Geneva / /

IndustryTerm

finished pharmaceutical product / manufacturing practices / manufacturing sites / selected products / pharmaceutical product / manufacturing / manufacturing site / clinical management / specified manufacturing site / active pharmaceutical ingredients / pharmaceutical manufacturers / pharmaceutical products / policy makers / medicinal products / /

MedicalCondition

disease / /

MedicalTreatment

oral rehydration / /

Organization

37th WHO Expert Committee on Specifications for Pharmaceutical Preparations / United Nations International Children's Emergency Fund / United States Agency for International Development / World Health Organization / United Nations / WHO Department of Child and Adolescent Health / /

Product

zinc sulfate / /

URL

http /

SocialTag